287 related articles for article (PubMed ID: 19700744)
1. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation.
Singh N; Chin I; Gabriel P; Blaum E; Masli S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.
Contreras-Ruiz L; Regenfuss B; Mir FA; Kearns J; Masli S
PLoS One; 2013; 8(9):e75937. PubMed ID: 24086667
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
6. TSP-1 Deficiency Alters Ocular Microbiota: Implications for Sjögren's Syndrome Pathogenesis.
Terzulli M; Contreras-Ruiz L; Kugadas A; Masli S; Gadjeva M
J Ocul Pharmacol Ther; 2015 Sep; 31(7):413-8. PubMed ID: 26352162
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA
Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738
[TBL] [Abstract][Full Text] [Related]
8. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
10. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
11. Lacrimal Gland Epithelial Cells Shape Immune Responses through the Modulation of Inflammasomes and Lipid Metabolism.
Delcroix V; Mauduit O; Yang M; Srivastava A; Umazume T; de Paiva CS; Shestopalov VI; Dartt DA; Makarenkova HP
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901740
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
13. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome: pathogenesis.
Tabbara K; Sharara N
Eur J Ophthalmol; 1999; 9(1):1-7. PubMed ID: 10230585
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
18. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.
Zhou D; Chen YT; Chen F; Gallup M; Vijmasi T; Bahrami AF; Noble LB; van Rooijen N; McNamara NA
Am J Pathol; 2012 Sep; 181(3):753-60. PubMed ID: 22770665
[TBL] [Abstract][Full Text] [Related]
19. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.
De Paiva CS; Hwang CS; Pitcher JD; Pangelinan SB; Rahimy E; Chen W; Yoon KC; Farley WJ; Niederkorn JY; Stern ME; Li DQ; Pflugfelder SC
Rheumatology (Oxford); 2010 Feb; 49(2):246-58. PubMed ID: 20007286
[TBL] [Abstract][Full Text] [Related]
20. Mouse Models of Sjögren's Syndrome with Ocular Surface Disease.
Masli S; Dartt DA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
